Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial
- DOI
- 10.1038/s41591-026-04644-8
- Published
- 2026-09-15
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04644-8,
title = {Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial},
author = {Marcilio J. Fumagalli and Anna Kaczynska and Marius Allombert and Ágata Lopes-Ribeiro and Mariângela de Oliveira Silva and Brianna J. Hernandez and Christy Lavine and Sebastian M. Espinosa and Helen Brown and Hanna Box and Emanuela Falaschetti and Louise-Rae Cherrill and Tamara Elliott and Ming Lee and Julie Fox and Sarah Pett and Amanda Clarke and Alison Uriel and Ole Sogaard and Rebecca Sutherland and Marta Boffito and Sabine Kinloch-Loes and Chloe Orkin and Simon Collins and Panagiota Zacharopoulou and Nicola Robison and Cintia Bittar and Thiago Oliveira and Anna Gazumyan and Mila Jankovic and Michael S. Seaman and John Frater and Marina Caskey and Sarah Fidler and Michel C. Nussenzweig},
year = {2026},
journal = {Nature Medicine},
doi = {10.1038/s41591-026-04644-8},
url = {https://doi.org/10.1038/s41591-026-04644-8}
}RIS
TY - JOUR TI - Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial AU - Marcilio J. Fumagalli AU - Anna Kaczynska AU - Marius Allombert AU - Ágata Lopes-Ribeiro AU - Mariângela de Oliveira Silva AU - Brianna J. Hernandez AU - Christy Lavine AU - Sebastian M. Espinosa AU - Helen Brown AU - Hanna Box AU - Emanuela Falaschetti AU - Louise-Rae Cherrill AU - Tamara Elliott AU - Ming Lee AU - Julie Fox AU - Sarah Pett AU - Amanda Clarke AU - Alison Uriel AU - Ole Sogaard AU - Rebecca Sutherland AU - Marta Boffito AU - Sabine Kinloch-Loes AU - Chloe Orkin AU - Simon Collins AU - Panagiota Zacharopoulou AU - Nicola Robison AU - Cintia Bittar AU - Thiago Oliveira AU - Anna Gazumyan AU - Mila Jankovic AU - Michael S. Seaman AU - John Frater AU - Marina Caskey AU - Sarah Fidler AU - Michel C. Nussenzweig PY - 2026 JO - Nature Medicine DO - 10.1038/s41591-026-04644-8 UR - https://doi.org/10.1038/s41591-026-04644-8 ER -
APA
Fumagalli, M. J., Kaczynska, A., Allombert, M., Lopes-Ribeiro, Á., Silva, M. D. O., Hernandez, B. J., Lavine, C., Espinosa, S. M., Brown, H., Box, H., Falaschetti, E., Cherrill, L., Elliott, T., Lee, M., Fox, J., Pett, S., Clarke, A., Uriel, A., Sogaard, O., Sutherland, R., Boffito, M., Kinloch-Loes, S., Orkin, C., Collins, S., Zacharopoulou, P., Robison, N., Bittar, C., Oliveira, T., Gazumyan, A., Jankovic, M., Seaman, M. S., Frater, J., Caskey, M., Fidler, S., & Nussenzweig, M. C. (2026). Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04644-8
Source records
- crossref · retrieved 2026-09-25T06:01:17.720Z